Back to Search
Start Over
Reprogramming of chimpanzee fibroblasts into a multipotent cancerous but not fully pluripotent state by transducing iPSC factors in 2i/LIF culture.
- Source :
-
Differentiation; research in biological diversity [Differentiation] 2020 Mar - Apr; Vol. 112, pp. 67-76. Date of Electronic Publication: 2020 Feb 04. - Publication Year :
- 2020
-
Abstract
- To induce and maintain naïve pluripotency in mouse embryonic and induced pluripotent stem cells (ESCs/iPSCs), chemically defined N2B27 medium with PD0325901, CHIR99021, and leukemia inhibitory factor (2i/LIF) is a classic and simple condition. However, this method cannot be simply extrapolated to human ESCs/iPSCs that are principally stabilized in primed pluripotency and become primitive neuroepithelium-like cells in N2B27+2i/LIF culture. Here, we assessed iPSC reprogramming of fibroblasts from chimpanzee, our closest living relative, in N2B27+2i/LIF culture. Under this condition, chimpanzee cells formed alkaline phosphatase-positive dome-shaped colonies. The colony-forming cells could be stably expanded by serial passaging without a ROCK inhibitor. However, their gene expression was distinct from iPSCs and neuroepithelium. They expressed the OCT3/4 transgene and a subset of transcripts associated with pluripotency, mesenchymal-epithelial transition, and neural crest formation. These cells exhibited a differentiation potential into the three germ layers in vivo and in vitro. The current study demonstrated that iPSC reprogramming in N2B27+2i/LIF culture converted chimpanzee fibroblasts into a multipotent cancerous state with unique gene expression, but not fully pluripotent stem cells.<br />Competing Interests: Declaration of competing interest H.O. is a Scientific Advisory Board Member of San Bio Co. Ltd. The other authors have no competing interests.<br /> (Copyright © 2020 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Benzamides pharmacology
Cell Differentiation drug effects
Cellular Reprogramming drug effects
Diphenylamine analogs & derivatives
Diphenylamine pharmacology
Epithelial-Mesenchymal Transition genetics
Fibroblasts cytology
Fibroblasts drug effects
Germ Layers drug effects
Germ Layers growth & development
Humans
Leukemia Inhibitory Factor pharmacology
Mice
Multipotent Stem Cells drug effects
Neural Crest cytology
Pan troglodytes
Pluripotent Stem Cells cytology
Pluripotent Stem Cells drug effects
Pyridines pharmacology
Pyrimidines pharmacology
Cell Differentiation genetics
Cellular Reprogramming genetics
Induced Pluripotent Stem Cells cytology
Multipotent Stem Cells cytology
Subjects
Details
- Language :
- English
- ISSN :
- 1432-0436
- Volume :
- 112
- Database :
- MEDLINE
- Journal :
- Differentiation; research in biological diversity
- Publication Type :
- Academic Journal
- Accession number :
- 32045848
- Full Text :
- https://doi.org/10.1016/j.diff.2020.01.002